Long-Term Study of CartiPRO for Knee Pain Due to Osteoarthritis or Cartilage Damage

Summary

This clinical trial aims to evaluate and compare the efficacy and safety of CartiPRO, an approved intra-articular atelocollagen injection, versus Synovian injection for the relief of knee pain in patients with knee osteoarthritis. The investigational device is administered intra-articularly, with a second injection given 24 weeks after the first dose. Primary and secondary endpoints include changes in pain scores (VAS), functional assessments (WOMAC, SF-36), and safety evaluations over a 36-week period.

Timeline

Start

2025-07-03

Primary completion

2026-02

Completion

2026-10

Drugs

Indications